Fig. 1From: Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential cardioprotective mechanisms of vitamin D?Concentration of markers and 25(OH)D3 before (1) and after 3 months of cholecalciferol supplementation (2). A leptin, p = 0.029; B TMAO, p = 0.022; C NO, p = 0.021; D VEGF-A, p = 0.024; E sST2, p = 0.065; F 25(OH)D3, p < 0.001Back to article page